0303_article_10
Medications with anticholinergic effects classified by therapeutic... | Download Table
Anticholinergic drugs – TaperMD
Antidepressant Withdrawal and Rebound Phenomena (17.05.2019)
High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure - Innovations in Clinical Neuroscience : Innovations in Clinical Neuroscience
Ruling out delirium: therapeutic principles of withdrawing and changing medications - Document - Gale Academic OneFile
Tapering of SSRI treatment to mitigate withdrawal symptoms - The Lancet Psychiatry
Frontiers | Anticholinergic Drugs in Geriatric Psychopharmacology
Major Mental Illnesses - ppt download
Clozapine discontinuation withdrawal symptoms in schizophrenia - Graham Blackman, Ebenezer Oloyede, 2021
Antidepressant Withdrawal and Rebound Phenomena (17.05.2019)
PDF) A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder
Ruling out delirium: Therapeutic principles of withdrawing and changing medications | MDedge Psychiatry
Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse
The Cholinergic System in Schizophrenia Reconsidered: Anticholinergic Modulation of Sleep and Symptom Profiles | Neuropsychopharmacology
Psychosis Induced by Smoking Cessation Clinic Administered Anticholinergic Overload
Medications with anticholinergic effects classified by therapeutic... | Download Table
Targeting the cholinergic system in Parkinson's disease | Acta Pharmacologica Sinica
Characteristics of phase 3-like activity and rebound excitation triggered by hexamethonium and atropine administration in the ov
5 Things to Know About Psychotropic Medications and Dry Mouth
Diagnosis & Management of Antidepresssant Withdrawal - Focus on SSRIs
PDF) Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications - FullText - Psychotherapy and Psychosomatics 2020, Vol. 89, No. 5 - Karger Publishers
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens | ACS Chemical Neuroscience
